{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:58:06Z","timestamp":1792789086931,"version":"4.5.0"},"reference-count":43,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82260573"],"award-info":[{"award-number":["82260573"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"award":["82260573"],"award-info":[{"award-number":["82260573"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Hepatocellular carcinoma (HCC) heterogeneity, particularly the presence of tumor cells co-expressing hepatocytic and cholangiocytic markers, contributes to therapeutic resistance and poor prognosis, yet its molecular correlates remain incompletely understood. This study aimed to characterize dual-phenotype HCC (DPHCC) and investigate the association and functional relevance of SPINT2 in tumor progression. Methods: We integrated multiplex immunofluorescence, CyTOF mass cytometry, single-cell RNA sequencing, and functional assays across clinical cohorts and cell lines. Results: Multiplex staining identified DPHCC in 22.89% of patients, correlating significantly with younger age, elevated AFP, and inferior recurrence-free and overall survival compared to non-DPHCC cases. Parallel scRNA-seq and CyTOF analyses showed that DPHCC-associated cells were enriched for stemness- and EMT-related features, with SPINT2 emerging as a top candidate gene in the transcriptomic analysis. Immunohistochemistry showed higher SPINT2 expression in DPHCC tissues, and high SPINT2 expression was associated with shorter overall survival in univariate Kaplan\u2013Meier analysis and frequently co-localized with CK19. Functionally, SPINT2 modulation produced context-dependent changes in invasion, proliferation-related CCK-8 readouts, wound closure, sphere formation, and xenograft tumor growth in MHCC-97H and MHCC-LM3 cells. Collectively, these findings characterize DPHCC as a clinically relevant dual-lineage phenotypic state associated with aggressive tumor features and identify SPINT2 as a candidate molecule associated with this phenotype. Conclusions: SPINT2 is associated with the DPHCC-related state and aggressive tumor-cell phenotypes, but its mechanistic and clinical significance requires further validation.<\/jats:p>","DOI":"10.3390\/cancers18193102","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:06:37Z","timestamp":1790237197000},"page":"3102","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SPINT2 Is Associated with Dual-Phenotype Hepatocellular Carcinoma and Aggressive Tumor Features"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9181-1698","authenticated-orcid":false,"given":"Jie","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, China"},{"name":"Guangxi Key Laboratory of Early Prevention and Treatment of Regional High Frequency Tumors, Nanning 530021, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"}]},{"given":"Minjun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, China"},{"name":"Guangxi Key Laboratory of Early Prevention and Treatment of Regional High Frequency Tumors, Nanning 530021, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"given":"Taixin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, China"},{"name":"Guangxi Key Laboratory of Early Prevention and Treatment of Regional High Frequency Tumors, Nanning 530021, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7315-8835","authenticated-orcid":false,"given":"Ning","family":"Ma","sequence":"additional","affiliation":[{"name":"Division of Health Science, Graduate School of Health Science, Suzuka University of Medical Science, Suzuka 510-0293, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"validation","vocabulary":"credit"}]},{"given":"Yaohong","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Oncology, Guangxi Medical University, Nanning 530021, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"}]},{"given":"Chunye","family":"Fang","sequence":"additional","affiliation":[{"name":"School of Oncology, Guangxi Medical University, Nanning 530021, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1071-9751","authenticated-orcid":false,"given":"Chenglei","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, China"},{"name":"Guangxi Key Laboratory of Early Prevention and Treatment of Regional High Frequency Tumors, Nanning 530021, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"software","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"}]},{"given":"Bangde","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, China"},{"name":"Guangxi Key Laboratory of Early Prevention and Treatment of Regional High Frequency Tumors, Nanning 530021, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"validation","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1038\/s41467-021-24010-1","article-title":"Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma","volume":"12","author":"Ho","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12072-023-10615-9","article-title":"Integrating single-cell and bulk RNA sequencing reveals CK19\u2009+\u2009cancer stem cells and their specific SPP1\u2009+\u2009tumor-associated macrophage niche in HBV-related hepatocellular carcinoma","volume":"18","author":"Yang","year":"2024","journal-title":"Hepatol. Int."},{"key":"ref_3","first-page":"101008","article-title":"Primary liver cancer classification from routine tumour biopsy using weakly supervised deep learning","volume":"6","author":"Ouzir","year":"2024","journal-title":"JHEP Rep. Innov. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/PAP.0000000000000494","article-title":"Other Primary Epithelial Neoplasms of the Liver","volume":"32","author":"Szeto","year":"2025","journal-title":"Adv. Anat. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jare.2024.12.008","article-title":"CD34(+)CLDN5(+) tumor associated senescent endothelial cells through IGF2-IGF2R signaling increased cholangiocellular phenotype in hepatocellular carcinoma","volume":"76","author":"Zhu","year":"2025","journal-title":"J. Adv. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"218557","DOI":"10.1016\/j.canlet.2026.218557","article-title":"The BTN3A3-TOMM22 axis preserves mitochondrial homeostasis to facilitate HCC stemness and drug resistance","volume":"655","author":"Kang","year":"2026","journal-title":"Cancer Lett."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"101358","DOI":"10.1016\/j.jcmgh.2024.05.006","article-title":"Sorted-Cell Sequencing on HCC Specimens Reveals EPS8L3 as a Key Player in CD24\/CD13\/EpCAM-Triple Positive, Stemness-Related HCC Cells","volume":"18","author":"Tsui","year":"2024","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1186\/s12967-023-04425-8","article-title":"Deep dissection of stemness-related hierarchies in hepatocellular carcinoma","volume":"21","author":"Liang","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Ramirez Alvarez, C., Kee, C., Sharma, A.K., Thomas, L., Schmidt, F.I., Stanifer, M.L., Boulant, S., and Herrmann, C. (2021). The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009687"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"148141","DOI":"10.1016\/j.ijbiomac.2025.148141","article-title":"SPINT2 inhibits NEDD4L-mediated ACSL4 ubiquitination to promote ferroptosis and suppress gallbladder cancer progression","volume":"330","author":"Ye","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Guo, C., Tang, Y., Yang, Z., Li, G., and Zhang, Y. (2022). Hallmark-guided subtypes of hepatocellular carcinoma for the identification of immune-related gene classifiers in the prediction of prognosis, treatment efficacy, and drug candidates. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.958161"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.hbpd.2026.03.002","article-title":"Clinicopathological features and prognosis of dual-phenotype hepatocellular carcinoma after curative hepatectomy: A propensity score matching analysis","volume":"25","author":"Zhu","year":"2026","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.2147\/JHC.S549670","article-title":"Adjuvant TACE Improves Prognosis After Resection in Dual-Phenotype Hepatocellular Carcinoma: A Propensity Score-Matched Study","volume":"12","author":"Leng","year":"2025","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.7150\/jca.56005","article-title":"Integrated Genomic and Transcriptomic Analysis reveals key genes for predicting dual-phenotype Hepatocellular Carcinoma Prognosis","volume":"12","author":"Wang","year":"2021","journal-title":"J. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2147\/JHC.S493094","article-title":"The Clinical Characteristics, Patterns of Recurrence, and Long-Term Survival Outcomes of Dual-Phenotype Hepatocellular Carcinoma After Curative Liver Resection","volume":"12","author":"Yu","year":"2025","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.7150\/jca.41090","article-title":"Overexpression of Epcam and CD133 Correlates with Poor Prognosis in Dual-phenotype Hepatocellular Carcinoma","volume":"11","author":"Zhang","year":"2020","journal-title":"J. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1038\/s41598-024-53831-5","article-title":"Analysis of clinicopathologic and imaging features of dual-phenotype hepatocellular carcinoma","volume":"14","author":"Huang","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e15734056413164","DOI":"10.2174\/0115734056413164251119094539","article-title":"Comparative Analysis of Clinical and MR Imaging Characteristics between Dual-Phenotype Hepatocellular Carcinoma and Conventional Hepatocellular Carcinoma: A Retrospective Study","volume":"22","author":"Yang","year":"2026","journal-title":"Curr. Med. Imaging"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/jmri.28391","article-title":"Preoperative Diagnosis of Dual-Phenotype Hepatocellular Carcinoma Using Enhanced MRI Radiomics Models","volume":"57","author":"Wu","year":"2023","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/HEP.0000000000000875","article-title":"Nuclear KRT19 is a transcriptional corepressor promoting histone deacetylation and liver tumorigenesis","volume":"81","author":"Han","year":"2025","journal-title":"Hepatology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/cas.13949","article-title":"Frizzled 2-induced epithelial-mesenchymal transition correlates with vasculogenic mimicry, stemness, and Hippo signaling in hepatocellular carcinoma","volume":"110","author":"Ou","year":"2019","journal-title":"Cancer Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.7150\/thno.32462","article-title":"ZnAs@SiO(2) nanoparticles as a potential anti-tumor drug for targeting stemness and epithelial-mesenchymal transition in hepatocellular carcinoma via SHP-1\/JAK2\/STAT3 signaling","volume":"9","author":"Huang","year":"2019","journal-title":"Theranostics"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e02409","DOI":"10.1002\/advs.202502409","article-title":"Dual-Targeted Nanovesicles Induced Cancer Stem-Like Cell Differentiation to Sensitize Hepatocellular Carcinoma Radiotherapy","volume":"12","author":"Cao","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"760","DOI":"10.21873\/cgp.20535","article-title":"PPIL1 Drives Hepatocellular Carcinoma Progression and Cancer Stem Cell Self-renewal Through DAAM2-mediated Wnt\/\u03b2-Catenin Activation","volume":"22","author":"Wu","year":"2025","journal-title":"Cancer Genom. Proteom."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"7863","DOI":"10.1038\/s41467-023-43670-9","article-title":"SPINK1-induced tumor plasticity provides a therapeutic window for chemotherapy in hepatocellular carcinoma","volume":"14","author":"Man","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e8882","DOI":"10.1590\/1414-431x20198882","article-title":"Puerarin inhibits hepatocellular carcinoma invasion and metastasis through miR-21-mediated PTEN\/AKT signaling to suppress the epithelial-mesenchymal transition","volume":"53","author":"Zhou","year":"2020","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ge, X., Yao, Y., Li, J., Li, Z., and Han, X. (2021). Role of LncRNAs in the Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.690800"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1007\/s00432-019-03062-3","article-title":"Radiomics for diagnosis of dual-phenotype hepatocellular carcinoma using Gd-EOB-DTPA-enhanced MRI and patient prognosis","volume":"145","author":"Huang","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/ajcp\/aqad143","article-title":"Microvascular invasion is associated with poor survival in patients with dual-phenotype hepatocellular carcinoma","volume":"161","author":"Ouyang","year":"2024","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_30","first-page":"2113","article-title":"DNMT1-mediated SPINT2 expression drives early senescence by suppressing c-Met signaling in human fibroblasts","volume":"17","author":"Sim","year":"2025","journal-title":"Aging"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41419-019-1659-1","article-title":"STYK1 promotes tumor growth and metastasis by reducing SPINT2\/HAI-2 expression in non-small cell lung cancer","volume":"10","author":"Ma","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s13402-019-00475-7","article-title":"Loss of SPINT2 expression frequently occurs in glioma, leading to increased growth and invasion via MMP2","volume":"43","author":"Pereira","year":"2020","journal-title":"Cell. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1111\/cas.13732","article-title":"Aberrant methylation and silencing of the SPINT2 gene in high-grade gliomas","volume":"109","author":"Fukushima","year":"2018","journal-title":"Cancer Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.biopha.2018.02.100","article-title":"Serine peptidase inhibitor Kunitz type 2 (SPINT2) in cancer development and progression","volume":"101","author":"Roversi","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00432-002-0396-4","article-title":"Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray","volume":"129","author":"Li","year":"2003","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.18632\/oncotarget.6603","article-title":"miR-192, a prognostic indicator, targets the SLC39A6\/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma","volume":"7","author":"Lian","year":"2016","journal-title":"Oncotarget"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.18632\/oncotarget.2003","article-title":"HGF\/MET-directed therapeutics in gastroesophageal cancer: A review of clinical and biomarker development","volume":"5","author":"Hack","year":"2014","journal-title":"Oncotarget"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.32604\/or.2025.063719","article-title":"Advances in Tumor Microenvironment and Immunotherapeutic Strategies for Hepatocellular Carcinoma","volume":"33","author":"Xue","year":"2025","journal-title":"Oncol. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.7150\/thno.95971","article-title":"Single cell analyses reveal the PD-1 blockade response-related immune features in hepatocellular carcinoma","volume":"14","author":"Li","year":"2024","journal-title":"Theranostics"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Wang, Z., Li, X., Zhang, S., Sun, J., Lu, Q., Tao, Y., Liang, S., Lan, X., Zhong, J., and Wang, Q. (2025). The SMIM25-COX-2 Axis Modulates the Immunosuppressive Tumor Microenvironment and Predicts Immunotherapy Response in Hepatocellular Carcinoma. Curr. Issues Mol. Biol., 47.","DOI":"10.3390\/cimb47090693"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3892\/ol.2020.12308","article-title":"Fibrinogen-like protein 2 promotes the accumulation of myeloid-derived suppressor cells in the hepatocellular carcinoma tumor microenvironment","volume":"21","author":"Liu","year":"2021","journal-title":"Oncol. Lett."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s40164-024-00539-x","article-title":"Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: From bench to bedside","volume":"13","author":"Yin","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41392-025-02520-4","article-title":"Dysadherin\/YAP axis fuels stem plasticity and immune escape in liver cancer","volume":"10","author":"Jang","year":"2025","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/19\/3102\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:16:20Z","timestamp":1790396180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/19\/3102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":43,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["cancers18193102"],"URL":"https:\/\/doi.org\/10.3390\/cancers18193102","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]}}}